Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion

Background: Faster aspart is insulin aspart (IAsp) in a new formulation, which in continuous subcutaneous insulin infusion (CSII) in subjects with type 1 diabetes has shown a faster onset and offset of glucose-lowering effect than IAsp. Methods: This double-blind, randomized, crossover active-contro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Technol Ther
Autors principals: Bode, Bruce W., Johnson, Joseph A., Hyveled, Liselotte, Tamer, Søren C., Demissie, Marek
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5248540/
https://ncbi.nlm.nih.gov/pubmed/28055230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2016.0350
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars